migraines after the first dose lasted for 4-5 days; joint pain after the first dose lasted for 4-5 days; body aches after the first dose lasted for 4-5 days; severe fever after the first dose lasted for 4-5 days; fatigue after the first dose lasted for 4-5 days; nausea after the first dose lasted for 4-5 days; vomiting after the first dose lasted for 4-5 days; This spontaneous case was reported by an other health care professional and describes the occurrence of MIGRAINE (migraines after the first dose lasted for 4-5 days), ARTHRALGIA (joint pain after the first dose lasted for 4-5 days), MYALGIA (body aches after the first dose lasted for 4-5 days), PYREXIA (severe fever after the first dose lasted for 4-5 days) and FATIGUE (fatigue after the first dose lasted for 4-5 days) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014F2V9) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (COVID outcome: this year she had respiratory symptoms, flare ups of joint inflammation, ovary pain.) on 03-May-2021, Pneumonia (ended up with pneumonia 3 times) in 2020, Interstitial lung disease in 2020, Joint inflammation (flare ups of joint inflammation), Ovarian pain in 2021, Respiratory symptom, COVID-19 in April 2020, Lung operation in 2020, Biopsy in 2020, Intrauterine contraception and Hospitalization (In 2020, the patient was hospitalized 3 times, ended up with pneumonia 3 times; had surgery in lungs: biopsy; she was diagnosed with interstitial lung disease) in 2020. Concurrent medical conditions included Cyst.    On 04-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In October 2021, the patient experienced MIGRAINE (migraines after the first dose lasted for 4-5 days), ARTHRALGIA (joint pain after the first dose lasted for 4-5 days), MYALGIA (body aches after the first dose lasted for 4-5 days), PYREXIA (severe fever after the first dose lasted for 4-5 days), FATIGUE (fatigue after the first dose lasted for 4-5 days), NAUSEA (nausea after the first dose lasted for 4-5 days) and VOMITING (vomiting after the first dose lasted for 4-5 days). The patient was treated with IBUPROFEN for Adverse event, at a dose of 1 dosage form; PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at a dose of 1 dosage form; TAPENTADOL HYDROCHLORIDE (NUCYNTA) for Adverse event, at a dose of 100 milligram; LACIDIPINE (TENS) for Adverse event, at a dose of 1 dosage form and MENTHOL (ICE [MENTHOL]) for Adverse event, at a dose of 1 dosage form. In October 2021, MIGRAINE (migraines after the first dose lasted for 4-5 days), ARTHRALGIA (joint pain after the first dose lasted for 4-5 days), MYALGIA (body aches after the first dose lasted for 4-5 days), PYREXIA (severe fever after the first dose lasted for 4-5 days), FATIGUE (fatigue after the first dose lasted for 4-5 days), NAUSEA (nausea after the first dose lasted for 4-5 days) and VOMITING (vomiting after the first dose lasted for 4-5 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information provided by the reporter. Treatment medication included migraine medicine but patient was not responding to it.  On 2021 Patient was not hospitalized but went to urgent care, they heard rumbling in the lungs and sent her to the hospital.   This case was linked to MOD-2021-375286 (Patient Link).